<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32462798</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant.</ArticleTitle><Pagination><StartPage>965</StartPage><EndPage>971</EndPage><MedlinePgn>965-971</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51064</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The NEK1 gene has been recently implicated in amyotrophic lateral sclerosis (ALS). This study aims to assess the influence of NEK1 variants on the occurrence of ALS and investigate the spectrum and clinical features of NEK1 loss-of-function (LOF) variants in a Taiwanese ALS cohort.</AbstractText><AbstractText Label="METHODS">We screened 325 unrelated ALS patients for coding variants in NEK1 by targeted resequencing and queried the Taiwan Biobank database for NEK1 coding variants in 1000 Taiwanese healthy individuals. The clinical features of the patients with a NEK1 LOF variant were analyzed.</AbstractText><AbstractText Label="RESULTS">Six patients and two healthy individuals carried NEK1 LOF variants. The rare missense variants with minor allele frequencies &lt;0.1% in Taiwanese population were present in 2.8% of the ALS patients and 1.6% of the healthy subjects. NEK1 LOF variants, but not rare missense variants, are significantly enriched in the ALS patients (P&#xa0;=&#xa0;0.0037 and 0.24, Fisher's exact test). The odds ratio of an individual carrying a NEK1 LOF variant to develop ALS is 9.39 (95% confidence interval: 1.88-46.7). All the six patients carrying a NEK1 LOF variant had a hand-onset ALS with an onset age from 52 to 64&#xa0;years. Comparing with ALS patients without a NEK1 LOF variant, patients with a NEK1 LOF variant tend to have a hand-onset disease (P&#xa0;=&#xa0;0.0008, Fisher's exact test).</AbstractText><AbstractText Label="INTERPRETATION">Our study supports the pathogenic role of NEK1 LOF variants and demonstrates their spectrum and clinical features in a Taiwanese cohort with ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yu-Shuen</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Center for Systems and Synthetic Biology, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Kon-Ping</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jih</LastName><ForeName>Kang-Yang</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Pei-Chien</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yi-Chu</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0002-9644-2086</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yi-Chung</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0003-0102-164X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Research Center, National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000606914">NEK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000072380">NIMA-Related Kinase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006225" MajorTopicYN="N">Hand</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073658" MajorTopicYN="N">Loss of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072380" MajorTopicYN="N">NIMA-Related Kinase 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32462798</ArticleId><ArticleId IdType="pmc">PMC7318098</ArticleId><ArticleId IdType="doi">10.1002/acn3.51064</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Testa D, Lovati R, Ferrarini M, et al. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28&#x2010;year period. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:208&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">15799548</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH Jr. Emerging mechanisms of molecular pathology in ALS. J Clin Invest 2015;125:1767&#x2013;1779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 2015;347:1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PT, Dekker AM, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 2016;48:1037&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, M&#xfc;ller K, Wieland T, et al. NEK1 mutations in familial amyotrophic lateral sclerosis. Brain 2016;139:e28.</Citation><ArticleIdList><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan SMK, Howrigan DP, Abbott LE, et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat&#x2010;shock protein. Nat Neurosci 2019;22:1966&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Craigen WJ, Riley DJ. Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. 9. Cell Cycle 2009;8:257&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673983</ArticleId><ArticleId IdType="pubmed">19158487</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelegrini Al, Moura DJ, Brenner Bl, et al. Nek1 silencing slows down DNA repair and blocks DNA damage&#x2010;induced cell cycle arrest. Mutagenesis 2010;25:447&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">20501547</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalom O, Shalva N, Altschuler Y, Motro B. The mammalian Nek1 kinase is involved in primary cilium formation. FEBS Lett 2008;582:1465&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pubmed">18387364</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Lin H, Wang X, et al. The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Acta Biochim Biophys Sin 2015;10:834&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581587</ArticleId><ArticleId IdType="pubmed">26290490</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Shatunov A, Dekker AM, et al. Genome&#x2010;wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet 2016;48:1043&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria &#x2010; 2015. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:291&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Soong BW, Lin KP, Guo YC, et al. Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 2014;35:2423.e1&#x2013;2423.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24908169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin KP, Tsai PC, Liao YC, et al. Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 2015;36:2005.e1&#x2013;2005.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25771394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai PC, Liu YC, Lin KP, et al. Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 2016;40:191.e11&#x2013;191.e16.</Citation><ArticleIdList><ArticleId IdType="pubmed">26804609</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai PC, Liao YC, Chen PL, et al. Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis. Neurobiol Aging 2018;62:243.e1&#x2013;243.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29102476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CH, Yang JH, Chiang CWK, et al. Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet 2016;25:5321&#x2013;5331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078601</ArticleId><ArticleId IdType="pubmed">27798100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Mossevelde S, Dillen L, et al. NEK1 genetic variability in a Belgian cohort of ALS and ALS&#x2010;FTD patients. Neurobiol Aging 2018;61:255.e1&#x2013;255.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu S, Lei X, Liu F, et al. Mutation screening of NEK1 in Chinese ALS patients. Neurobiol Aging 2018;71:267.e1&#x2013;267.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">30093141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. ALS phenotype is influenced by age, sex, and genetics: a population&#x2010;based study. Neurology 2020;94:e802&#x2013;e810.</Citation><ArticleIdList><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>